1,3-Bis(4-fluorophenyl)urea, 98%, 5g

tert-butyl (3R)-3-fluoro-4-oxopiperidine-1-carboxylate, 95.0%, 500mg

4-CYANOPHENYL 4-PROPYL-BENZOATE, 97.0%, 5g

4-Fluorophenyl glyoxal hydrate, 95.0%, 100g

5,5-Bis(hydroxymethyl)-2-phenyl-1,3-dioxane, 98.0%, 25g

Phenyl 2,4,6-Tri-O-acetyl-3-O-allyl-1-thio-beta-D-glucopyranoside>98.0%(HPLC)1g

Ethyl N-(tert-butoxycarbonyl)-N-ethylglycinate, 95+%, 1g

5-Chlorothiophene-2-carbonyl Chloride>98.0%(GC)(T)25g

4-amino-6-(4-methoxyphenyl)pyridazin-3(2{H})-one, 95.0%, 500mg

1,1,1-Tris(2-cyanoethyl)nitromethane, 96%, 25g

Hydroxyde de sodium, min 97%, pa, ACS, en pastilles, 500 g, emballage plastique.

tert-Butyl 3-oxo-1-oxa-7-azaspiro[4.4]nonane-7-carboxylate, 95.0%, 250mg

2-Chloro-4-(cyclopropylamino)pyrimidine-5-carboxylic acid, 95.0%, 1g